The use of intravenous ethanol for anaesthesia has been in the past condemned following the high incidence of venous complications, mainly thrombosis in the vein used for infusion (Adams, 1944) . To a large extent this is attributable to the high concentrations of ethanol employed by these previous workers. In a recent paper (Dundee, Isaac and Clarke, 1969) it was shown that the anaesthetic potentialities of this drug could be exploited by employing low concentrations but with rapid infusion rates. However, in the light of previous reports of venous complications the effect of this drug on veins was studied and to obtain comparable data this study was based on the method employed by Hewitt and colleagues (1966) . METHOD A standard 18 s.w.g. infusion needle was used following local infiltration with lignocaine and 80-120 ml/min of ethanol was infused up to a total of 550 ml generally made up in Hartmann's (Ringer-lactate) solution. At the end of the infusion the needle was withdrawn and firm pressure was applied at the site of venepuncture with a sterile swab and strapping.
The following observations were made: (a) The occurrence of pain on infusion at the site of puncture or in the arm. This was graded as mild (elicited only on direct questioning) or severe, where the patient complained spontaneously.
(b) The state of the vein was studied 24 and 48 hours postinfusion and the criteria of Hewitt and colleagues (1966) were employed, noting the presence or absence of (i) tenderness on palpation of the vein; (ii) thrombosis in the vessel lumen. From these signs the venous sequelae were classified as: phlebitis (tenderness without thrombosis); thrombosis (without phlebitis); thrombophlebitis (combination of both). These sequelae were graded as localized (under 2.4 cm) or extended. Table I shows the results from the first 260 patients studied. Varying concentrations of ethanol were employed at random in this series and the majority of these observations were made personally by the authors.
RESULTS
The highest incidence of pain on infusion was observed with 10 per cent (w/v) solution and, surprisingly, the next highest incidence was noted with 7 per cent (w/v). These two concentrations also produced the highest incidence of detectable venous sequelae.
Subsequent to this study, 8 per cent (w/v) of ethanol only has been used routinely with less detailed follow-up and with more observers. The data from these cases are summarized in It was observed that when pain on infusion did occur it was generally very transient and had usually passed off by 1 minute. In only one case out of a total of 400 did the pain persist to the extent of having to abandon the infusion.
DISCUSSION
No explanation can be found for the paradoxical findings in table I, in which 7 per cent solution caused more pain on infusion and sequelae than the 8 per cent. However, results clearly show that 7 and 10 per cent solutions are best avoided in clinical practice. Although pain on infusion and sequelae were less frequent with the more dilute solutions (5 and 6 per cent) clinical experience has shown that it is often difficult to achieve blood anaesthetic levels of alcohol with these and thus the 8 per cent is preferred for routine use. This has the additional advantage of being simple to prepare by adding 55 ml of absolute alcohol to 500 ml of perfusate.
Comparing the findings from the use of 8 per cent solution with those reported by Hewitt and associates (1966) and O'Donnell, Hewitt and Dundee (1969) , it would appear that this concentration causes a higher incidence of venous sequelae than do clinical doses of thiopentone or methohexitone, but that the incidence is similar to that noted after injection of propanidid. CORRESPONDENCE continued from p. 1069 moderate hypocapnia should be maintained after discontinuing first the halothane and subsequently the nitrous oxygen preferably until the pre-operative level of consciousness has been regained. This may take several hours. Under no circumstance can it be justified to "wake up" the patient using a rebreathing system for letting carbon dioxide accumulate. Controlled hyperyentilation during recovery from anaesthesia is especially important in head injury cases where risks of vomiting and aspirating gastric contents are increased.
(4) The blood pressure decreases with the combined effect of chlorprornazine, barbiturates, halothane, and hypocapnia. Especially in the initial phase of anaesthesia, and if surgery is not carried out, the blood pressure may fall quite markedly. As is the general practice in most clinics a moderate level of hypotension (at a blood pressure level of approximately 80 per cent of the pre-operative or the assessed normal level) is acceptable. Development of lower pressures is counteracted by fluid administration (we use plasma or glucose 6 per cent in an amount of 1-2 litres if no bleeding occurs) and with hypsrtonic urea (we use 0.75 to 1.00 g/kg).
No comments will be given here regarding the use of the profound hypotension used for certain types of neurosurgery. Such lowering of the blood pressure is, when necessary, easily achieved by means of postural tilt and the occasional use of hypertensive agents; it should as a matter of principle be of as brief duration as possible and preferably combined with moderate hypothermia (30-32 °C) . A discussion of the various measures used for using brain bulk also lies beyond the scope of this discussion.
(5) A timely warning which was explicitly made in the Editorial concerns brief halothane anaesthesias in patients with intracranial space-occupying lesions. In such anaesthetics, often used in conjunction with neuroradiological studies, precisely the same precautions as discussed above must be taken, namely: careful induction; intubation, controlled moderate hypocapnia maintained during and after anaesthesia until adequate recovery has been reached and with proper precautions against vomiting and aspiration; as the "stimulus" of surgery is absent, hypotension is apt to be relatively more pronounced and it must be counteracted by fluid administration and/or hyperosmotic therapy. Without proper attention to these problems a most dangerous triad of intracranial hypertension, hypercapnia and (despite the hypercapnia) systemic hypotension can arise. This condition may well aggravate the clinical condition of critically ill patients, i.e. precisely those patients who cannot tolerate any further brain tissue damage. Often the neuroradiological procedure is blamed for what really is due to the anaesthetic technique used and its complications (including aspiration of gastric contents). In addition, it may be affirmed, as the Editorial also mentioned, that an angiograpruc study made during a state of cerebral vasodilatation (as during halothane combined with normal or high Paco 2 values) may be falsely interpreted as normal. This is so because the blood flow decreases in the damaged tissue (e.g., around a tumour or in an area of brain contusion) due to the above-mentioned "intracerebral steal" effects.
It is our conclusion that low doses of halothane (0.5 per cent) can be used safely in neurosurgery, but only when used in combination with other techniques. In particular the risks of brief inadequate anaesthesias can hardly be overemphasized. Safer drugs and procedures will undoubtedly be developed. At present, however, none of the alternative modes of conducting routine neuro-anaesthesia can be stated to be of assured superior value to the mode described here. And, more important, the somewhat complex pattern of considerations which the neuro-anaesthetist must be able to comprehend and make use of (cerebral blood flow, intracranial pressure, systemic blood pressure, Pa C o 2 , etc.) is undoubtedly here to stay. 
